4
Changes in Ownership
Design Therapeutics, Inc. Filed Acc 0001209191-22-020637
Director sold 590,880 shares at an average $19.07 ($11,266,197)
From the SEC's structured data for this filing
Trades in this filing
Xu Stella · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-18 | Sale : show line 1 in the form | −552,225 | $19.04 | $10,514,364 | 4,168,605 | I |
| 2022-03-18 | Sale : show line 2 in the form | −13,200 | $20.34 | $268,488 | 4,155,405 | I |
| 2022-03-21 | Sale : show line 3 in the form | −24,000 | $19.01 | $456,240 | 4,131,405 | I |
| 2022-03-22 | Sale : show line 4 in the form | −1,455 | $18.63 | $27,105 | 4,129,950 | I |
| Open-market sales · 590,880 sh · avg $19.07 · $11,266,197 | ||||||
Loading xslF345X03/doc4.xml…